Ranitidin PB

Ranitidin PB Brand names, Ranitidin PB Analogs

Ranitidin PB Brand Names Mixture

Tritec (ranitidine bismuth citrate salt)

Ranitidin PB Chemical_Formula

C₁₃H₂₂N₄O₃S

Ranitidin PB RX_link

http://www.rxlist.com/cgi/generic2/ranitbc.htm

Ranitidin PB fda sheet

Ranitidin_PB FDA

Ranitidin PB msds (material safety sheet)

Ranitidin_PB MSDS

Ranitidin PB Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidin PB Molecular Weight

314.405 g/mol

Ranitidin PB Melting Point

69-70 ^oC

Ranitidin PB H₂O Solubility

24.7 mg/mL

Ranitidin PB State

Solid

Ranitidin PB LogP

1.93

Ranitidin PB Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidin PB Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidin PB Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidin PB Absorption

Approximately 50% bioavailability orally.

Ranitidin PB side effects and Toxicity

LD₅₀=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidin PB Patient Information

PATIENT INFORMATION

Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidin PB Organisms Affected

Humans and other mammals